- $1.05bn
- $1.05bn
- $169.02m
- 84
- 32
- 67
- 64
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 73.5 | 122 | 165 | 145 | 169 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 59.5 | 85.1 | 118 | 113 | 111 |
Operating Profit | 14 | 36.7 | 46.8 | 32.7 | 57.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 12.9 | 34.7 | 45.2 | 25.1 | 50.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.2 | 27 | 33.2 | 17.6 | 41.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.2 | 27 | 33.2 | 17.6 | 41.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.2 | 27 | 33.2 | 17.6 | 41.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.398 | 1.19 | 1.41 | 0.673 | 1.77 |
Dividends per Share |